## ARE: Alexandria Real Estate Equities - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 -0.9% below STRENGTH zone (3.0-6.0%); PEG 844.20 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($42.66)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 1, Bearish: 9)

**1. Shareholders who lost money in shares of Alexandria Real Estate Equities, Inc. (NYSE: ARE) Should Contact Wolf Haldenstein Immediately**
- Source: GlobeNewswire | 20251215T162117 | Bearish | Relevance: 100%
- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors who purchased Alexandria Real Estate Equities (NYSE: ARE) shares between January 27, 2025, and October 27, 2025, that a federal securities class action has been filed. The lawsuit follows disappointing Q3 2025 financial results, including a cut to FFO guidance and a significant real estate impairment charge, which caused a substantial drop in stock price. Investors have until January 26, 2026, to seek appointment as lead plaintiff.

**2. ALEXANDRIA REAL ESTATE EQUITIES, INC. (NYSE: ARE) DEADLINE**
- Source: GlobeNewswire | 20251215T064720 | Bearish | Relevance: 100%
- Bernstein Liebhard LLP reminds investors of Alexandria Real Estate Equities, Inc. (NYSE: ARE) about an upcoming deadline for a securities fraud class action lawsuit. The lawsuit alleges misrepresentations regarding the company's Long Island City property, and investors who purchased shares between January 27, 2025, and October 27, 2025, are encouraged to contact the firm by January 26, 2026, to discuss their rights or to serve as a lead plaintiff. The firm has a strong track record, having recovered over $3.5 billion for clients since 1993.

**3. Has Alexandria Real Estate Equities Fallen Too Far After Its 52% Slide in 2025?**
- Source: Simply Wall Street | 20251214T192803 | Bullish | Relevance: 100%
- Alexandria Real Estate Equities has experienced a significant 52% slide year-to-date in 2025, but recent analysis suggests it may be undervalued. Discounted Cash Flow and Price to Sales ratios indicate the stock could be trading at a substantial discount compared to its intrinsic value and industry peers, despite concerns about life sciences office demand and interest rates. Investors can use "Narratives" to align their views with financial projections and determine whether to buy, hold, or sell the stock.

**4. ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Alexandria Real Estate Equities, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARE**
- Source: TMX Newsfile | 20251214T140754 | Bearish | Relevance: 100%
- Rosen Law Firm is encouraging investors of Alexandria Real Estate Equities, Inc. (NYSE: ARE) to join a securities class action lawsuit before the January 26, 2026 lead plaintiff deadline. The lawsuit alleges that the company made false and misleading statements regarding its revenue and FFO growth and the leasing value of its Long Island City property. Investors who purchased securities between January 27, 2025, and October 27, 2025, may be entitled to compensation.

**5. ARE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Alexandria Real Estate Equities, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!**
- Source: KHON2 | 20251214T120756 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Alexandria Real Estate Equities, Inc. (NYSE:ARE) on behalf of investors who purchased securities between January 27, 2025, and October 27, 2025. The lawsuit alleges that Alexandria made false and misleading statements about its Long Island City property, particularly concerning its leasing value as a life-science destination. Investors who suffered losses have until January 26, 2026, to request to be appointed as lead plaintiff.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 6)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Citigroup | $52 | $61 | -15% |
| 2025-12-04 | Evercore ISI Gr | $64 | $72 | -11% |
| 2025-12-04 | BMO Capital | $60 | $67 | -10% |
| 2025-12-04 | Baird | $67 | $73 | -8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Citigroup | main | Neutral |
| 2025-12-04 | Evercore ISI Gr | main | Outperform |
| 2025-12-04 | BMO Capital | main | Outperform |
| 2025-12-04 | Baird | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($0.00M) |
| Sells | 3 ($0.15M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Vanguard Group Inc: 14.9% (-1.1%)
- Blackrock Inc.: 10.0% (-10.7%)
- State Street Corpora: 6.5% (+3.7%)
- Apg Asset Management: 3.9% (0.0%)
- JPMORGAN CHASE & CO: 3.3% (+34.1%)

### Key Risks

1. Valuation risk: PEG 844.2x with declining EPS estimates leaves no margin for error.
2. Long-term trend broken: trading 38.2% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 844.20 signals overvaluation risk, limited margin of safety. Revenue declining -6% YoY, concerning. Analyst sentiment negative (6 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.1B |
| Beta | 1.33 |
| 52W Range | $44.10 - $105.14 |
| Short Interest | 4.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 844.20 |
| Forward P/E | 241.7 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from -11.6% to -0.9% (+10.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.9pp (needs >3.0% for momentum thesis). MRS_5 turning positive (3.2%) - potential reversal signal. Below SMA200 (0.62x), long-term trend not supportive. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.92% (CS: 19) | Neutral |
| RSI_14 | 33.4 | Neutral |
| MACD Histogram | 0.28 | Bullish |
| vs SMA20 | 0.942x | Below |
| vs SMA50 | 0.772x | Below |
| vs SMA200 | 0.618x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $46.64
- **Stop Loss:** $42.66 (8.5% risk)
- **Target:** $50.62 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 301
- **Position Value:** $14,038.64
- **Portfolio %:** 14.04%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-01-26 (Est: $0.42)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.39 | $0.50 | +28.2% |
| 2025Q2 | $0.63 | $0.48 | -24.0% |
| 2025Q1 | $0.60 | $0.51 | -15.5% |
| 2024Q4 | $0.90 | $0.69 | -23.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*